Pacira Pharma (PCRX) Misses Q1 EPS by 104c

Pacira Pharma (NASDAQ: PCRX) reported Q1 EPS of ($0.43), $1.04 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $160.3 million versus the consensus estimate of $159.1 million.

For earnings history and earnings-related data on Pacira Pharma (PCRX) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Wall Street scrambles to lift Micron price targets ahead of earnings